|
|
Westaim Corporation (The) - Comparative Business Analysis Snapshot
Business Description
Westaim Corporation (The). The Group's principal activities are to develop, manufacture and commercialize medical products that fight infection and inflammation. The Group operates through two segments: NUCRYST Pharmaceuticals and iFire Technology. NUCRYST Pharmaceuticals segment researches, develops and commercializes wound care products and pharmaceutical products based on noble metal nanocrystalline technology. iFire Technology segment develops proprietary flat-panel full color solid-state display technology. The Group operates in Canada, the United States and Europe.
Competitor Analysis
This analysis compares Westaim Corporation (The) with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
